Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
86.06
-2.27 (-2.58%)
At close: Jun 15, 2026, 4:00 PM EDT
86.19
+0.13 (0.16%)
After-hours: Jun 15, 2026, 4:10 PM EDT
Apogee Therapeutics Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Apogee Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $119.5. The average 1-year stock price forecast is 38.86% higher than the current stock price, while the lowest is $81 (-5.87%) and the highest is $160 (+85.93%).
Price Target: $119.5 (+38.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Apogee Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 15 | 14 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $131 | Buy | Maintains | $131 | +52.23% | Jun 12, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $89 | Hold | Maintains | $89 | +3.42% | Jun 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $82 → $97 | Hold | Maintains | $82 → $97 | +12.72% | Jun 8, 2026 |
| Citi | Citi | Buy Maintains $125 | Buy | Maintains | $125 | +45.26% | May 28, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $130 | Buy | Maintains | $130 | +51.07% | May 28, 2026 |
Financial Forecast
Revenue This Year
7.69M
Revenue Next Year
10.71M
from 7.69M
Increased by 39.29%
EPS This Year
-4.44
from -4.22
EPS Next Year
-5.19
from -4.44
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100.0M | ||
| Avg | 7.7M | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 1,200.0% | |
| Avg | 39.3% | |
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.25 | ||
| Avg | -4.44 | ||
| Low | -5.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |